It binds plasma proteins more tightly and is retained far longer, which is why a single dose holds therapeutic levels for roughly eight to twelve weeks and supports a maintenance interval of two to three months
AOD-9604 produces fat loss without any IGF-1 elevation, preserves normal glucose metabolism and insulin sensitivity, does not promote muscle growth or tissue proliferation, shows minimal fluid retention or edema, and requires less intensive monitoring due to absence of systemic effects
Safety, Pharmacology, and Regulatory Science : Studying how AOD 9604 is absorbed, distributed, metabolized, and excreted in the body, as well as comparing its safety profile with that of full-length growth hormone
Growth hormone secretagogues elevate GH and subsequently can affect glucose